DK275285A - Leukotrienantagonister samt fremgangsmaade til fremstilling deraf - Google Patents

Leukotrienantagonister samt fremgangsmaade til fremstilling deraf Download PDF

Info

Publication number
DK275285A
DK275285A DK275285A DK275285A DK275285A DK 275285 A DK275285 A DK 275285A DK 275285 A DK275285 A DK 275285A DK 275285 A DK275285 A DK 275285A DK 275285 A DK275285 A DK 275285A
Authority
DK
Denmark
Prior art keywords
hydrogen
alkyl
alkenyl
chem
procedures
Prior art date
Application number
DK275285A
Other languages
Danish (da)
English (en)
Other versions
DK275285D0 (da
Inventor
William Edward Bondinell
David Taylor Hill
Barry Michael Weichman
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of DK275285D0 publication Critical patent/DK275285D0/da
Publication of DK275285A publication Critical patent/DK275285A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK275285A 1984-06-18 1985-06-18 Leukotrienantagonister samt fremgangsmaade til fremstilling deraf DK275285A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62140784A 1984-06-18 1984-06-18

Publications (2)

Publication Number Publication Date
DK275285D0 DK275285D0 (da) 1985-06-18
DK275285A true DK275285A (da) 1985-12-19

Family

ID=24490051

Family Applications (1)

Application Number Title Priority Date Filing Date
DK275285A DK275285A (da) 1984-06-18 1985-06-18 Leukotrienantagonister samt fremgangsmaade til fremstilling deraf

Country Status (11)

Country Link
EP (1) EP0168950B1 (de)
JP (1) JPS6112673A (de)
AT (1) ATE39922T1 (de)
AU (1) AU578101B2 (de)
CA (1) CA1242732A (de)
DE (1) DE3567454D1 (de)
DK (1) DK275285A (de)
ES (5) ES8700659A1 (de)
GR (1) GR851449B (de)
PT (1) PT80651B (de)
ZA (1) ZA854550B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3508665A1 (de) * 1985-03-12 1986-09-18 Hoechst Ag, 6230 Frankfurt Heterocyclische sulfide und ihre anwendung als immunmodulatoren
US4990526A (en) * 1985-06-18 1991-02-05 Merck Frosst Canada, Inc. Leukotriene antagonists, compositions and methods of use thereof
US4900744A (en) * 1988-09-14 1990-02-13 E. I. Du Pont De Nemours And Company Antihypercholesterolemic 4,5-diaryl-2-substituted thioimidazoles

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4311645A (en) * 1980-03-24 1982-01-19 Hoffmann-La Roche Inc. Synthesis of SRS-active compounds
DE3107599C2 (de) * 1981-02-27 1982-12-16 Ludwig Heumann & Co GmbH, 8500 Nürnberg N-Cyan-N'-methyl-N"-{2-[(5-methylthio-imidazol-4-yl)-methylthio]-äthyl}-guanidin, Verfahren zu seiner Herstellung und diese Verbindung enthaltende Arzneimittel

Also Published As

Publication number Publication date
PT80651A (en) 1985-07-01
PT80651B (en) 1987-04-28
ES8707198A1 (es) 1987-07-01
ES544268A0 (es) 1986-10-16
ES8707197A1 (es) 1987-07-01
DE3567454D1 (en) 1989-02-16
ES8707199A1 (es) 1987-07-01
ES555618A0 (es) 1987-07-01
EP0168950B1 (de) 1989-01-11
ZA854550B (en) 1986-04-30
ATE39922T1 (de) 1989-01-15
GR851449B (de) 1985-11-25
DK275285D0 (da) 1985-06-18
ES555616A0 (es) 1987-07-01
ES555619A0 (es) 1987-07-01
ES8700659A1 (es) 1986-10-16
AU578101B2 (en) 1988-10-13
ES555617A0 (es) 1987-07-01
EP0168950A1 (de) 1986-01-22
CA1242732A (en) 1988-10-04
ES8707196A1 (es) 1987-07-01
JPS6112673A (ja) 1986-01-21
AU4367685A (en) 1986-01-02

Similar Documents

Publication Publication Date Title
JPS5671074A (en) 1,2-disubstituted-4-halogenoimidazole-5-acetic acid derivative
IL74631A0 (en) 3-substituted 2-oxindole-1-carboxamides and pharmaceutical compositions containing them
NO820264L (no) Fremgangsmaate for fremstilling av 2-penemforbindelser
ES8304534A1 (es) "procedimiento de preparacion de derivados de 1-fenil-1-hidroxi-etilamina".
ES480850A1 (es) Procedimiento para preparar hidantoinas.
ES481729A1 (es) Procedimiento para la preparacion de derivados de 1,2-dihi- droquinolein-2-onas.
NZ234110A (en) Dibenzoazepine, -oxepine and -cycloheptane substituted alkylidene amines; pharmaceutical compositions containing such compounds or various other aryl substituted amines
ES8301881A1 (es) Un procedimiento para la preparacion de derivados de ariletanolamina que tienen actividad antiobesidad yno hploglicemi- ca.
ATE38991T1 (de) In 2-stellung substituierte 1,3propyledendephosphonat-derivate, ihre herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
SE7906472L (sv) Nya 3-(aminoetyl)-fenol-derivat och salter derav, sett for framstellning och anvendning derav sasom lekemedel samt farmaceutiska kompositioner innehallande dessa foreningar
ATE38028T1 (de) Cycloaliphatische heilmittelzusammensetzungen.
DK275285D0 (da) Leukotrienantagonister samt fremgangsmaade til fremstilling deraf
ES8404974A1 (es) Un procedimiento para la preparacion de eteres alquil-naftilicos.
ES8301865A1 (es) Procedimiento para la preparacion de fenil eteres y tioeteres sustituidos y sus sales.
IE832680L (en) Nitrosourea derivatives.
ES482684A1 (es) Procedimiento de preparacion de nuevos derivados de la pipe-ridilbencimidazolinona y de sus sales de adicion con acidos apropiados.
ES8802507A1 (es) Procedimiento para preparar eteres 1,3-dioxano.
ES8201171A1 (es) Procedimiento para la obtencion de eteres azolil-silil-gli- colidos de accion fungicida
ES8202826A1 (es) Procedimiento para la produccion de una 5,10-dihidroimidazo (2,1-b) quinazolina
FR2494274B2 (de)
ES8300709A1 (es) Un metodo para la preparacion de derivados de pirazolidinona
JPS56140902A (en) Preparation of concentrated fine powder